DrugNews: Yaz Settlements Up, Lawsuits Down In March Report
The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today.
Chicago, IL (PRWEB) March 25, 2014
The birth control safety advocates at DrugNews.net are alerting those women who have taken the oral contraceptives Yaz or Yasmin of the latest Yaz report on the site. Court records for March show the number of lawsuits alleging the drugs caused side effects like blood clots decreasing as the number of settlements rises*.
DrugNews is a free resource designed to give those taking popular prescription drugs the latest on product recalls, safety alerts, research and litigation news. Visitors can recognize potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added health warnings from experts including the FDA** and British Medical Journal*** that birth control containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots. The U.K.’s Medicines and Healthcare Products Regulatory Agency has also warned certain meds like Yasmin can double the risk of blood clots****.
Due to the number of patients who’ve filed a Yaz lawsuit alleging side effects, cases have been consolidated in a special federal court (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
Now, DrugNews has added the latest Yaz court records, showing the number of pending cases has fallen over 1% in less than a month, from 9,687 in February to 9,550 on March 13th*. The news comes as Bayer has spent $1.69 billion so far to settle around 8,250 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)*****.
Bayer says they will continue to evaluate new cases for settlement***** and lawyers are still helping those affected.
Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to visit DrugNews or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have settled hundreds of Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML, 3/13/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-March-13-2014.pdf
**FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
****British Journal of Family Medicine, Feb 2014; bjfm.co.uk/content/article.aspx?id=25769806997
*****Bayer Annual Report, Notes to Consolidated Financial Statement, Legal Risks, 2/28/14; annualreport2013.bayer.com/en/legal-risks.aspx
For the original version on PRWeb visit: http://www.prweb.com/releases/pulmonary-embolism-dvt/yasmin-yaz-settlement/prweb11697341.htm